Kadance
Kimberly Scott, MBA, currently serves as Chief Commercial Officer and Chief Marketing and Strategy Officer at Kadance. With a diverse and extensive career, Kimberly founded Genomicom and held the position of Senior Vice President of Marketing at Genomic Life. Previous roles include Vice President of Operations at United Pet Care, where responsibility entailed leading sales and operational strategies for growth, and multiple marketing positions at Illumina, including Senior Regional Marketing Manager. Kimberly also founded Global Event Associates and has a significant tenure at Applied Biosystems in various managerial and specialist roles. Educational credentials include an Executive MBA from Pepperdine Graziadio Business School, a certificate in Meeting and Event Planning from UC San Diego, and a BA in Physiology from Southern Illinois University, Carbondale. Additionally, Kimberly is a member of the Women Business Leaders of the US Health Care Industry Foundation for the 2024-2025 term.
This person is not in the org chart
This person is not in any teams
Kadance
Kadance is a genomics-based, precision health navigation company operating at the intersection of life insurance, life science, and health management. With a fully integrated, in-house genetics lab, Kadance is dedicated to simplifying and accelerating access to technologies and services that can dramatically alter an individual's health trajectory, with an initial focus on cancer and pharmacogenomics. Kadance designs and delivers tech-enabled, precision health management solutions through a network of life and critical insurance carriers. Kadance and its subsidiary, Kailos Genetics, LLC, are based at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. We are dedicated to simplifying and accelerating access to innovative technologies and services that can dramatically alter an individual's health trajectory for better health outcomes. Our programs provide policyholders day-one living benefit value, driving persistency, engagement, and improved mortality.